Innovita Biological Technology Co., Ltd. logo

Innovita Biological Technology Co., Ltd. (688253)

Market Closed
11 Aug, 06:57
SSE SSE
¥
66. 47
-4.87
-6.8265%
¥
4.52B Market Cap
- P/E Ratio
1.6% Div Yield
4.21M Volume
- Eps
¥ 71.34
Previous Close
Add Transaction
Day Range
65.52 72.31
Year Range
29.99 73.58
Want to track 688253 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688253 closed today lower at ¥66.47, a decrease of -6.8265% from yesterday's close, completing a monthly increase of 11.0795% or ¥6.63. Over the past 12 months, 688253 stock gained 119.8809%.
688253 is not paying dividends to its shareholders.
The last earnings report, released on Oct 25, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

688253 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Innovita Biological Technology Co., Ltd. (688253) FAQ

What is the stock price today?

The current price is ¥66.47.

On which exchange is it traded?

Innovita Biological Technology Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688253.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.6%.

What is its market cap?

As of today, the market cap is 4.52B.

Has Innovita Biological Technology Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Innovita Biological Technology Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Ms. Xiujie Zhang CEO
SSE Exchange
CNE100005Q14 ISIN
CN Country
404 Employees
16 Jun 2026 Last Dividend
- Last Split
- IPO Date

Overview

Innovita Biological Technology Co., Ltd., founded in 2006 and headquartered in Beijing, China, specializes in the research and development, manufacturing, marketing, and sales of POCT (Point of Care Testing) rapid diagnostic products. The company focuses on providing quick and accurate diagnostic solutions for a wide range of medical needs, including infectious diseases, outpatient emergencies, and health checks related to pregnancy and chronic diseases.

Products and Services

  • Pathogen Detection

    This service provides rapid diagnosis for a variety of pathogens, helping in the quick identification and management of infectious diseases.

  • Joint Detection of Multiple Pathogen

    Recognizing the complexity of co-infections, Innovita offers services for the joint detection of multiple pathogens, streamlining the diagnostic process for illnesses that may exhibit overlapping symptoms.

  • Emergency Outpatient Testing

    Designed for emergency and outpatient settings, this service facilitates the rapid diagnosis of conditions, ensuring timely treatment and intervention.

  • Coronavirus Testing

    In response to the global pandemic, Innovita provides reliable and swift testing solutions for the detection of the coronavirus, aiding in controlling the spread of the virus.

  • Respiratory Infections Solutions

    Focusing on one of the most common health concerns, Innovita offers diagnostic testing for a range of respiratory infections, supporting the effective treatment of these ailments.

  • Pregnancy Test

    Innovita's pregnancy testing products offer quick, accurate results for early detection, providing essential information for expectant mothers.

  • Hepatitis Virus Testing

    Offering rapid detection tests for different types of hepatitis virus, Innovita plays a critical role in the early diagnosis and management of this serious liver disease.

  • Enterovirus Testing

    This testing service is aimed at identifying enterovirus infections, which are common in children and can lead to various health issues.

Contact Information

Address: Building 6, Yard 1, Beijing, China, 100070
Phone: 86 10 8368 2249